Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of ...

Abivax presents third quarter 2024 key financial informationPARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: ...

Women's health innovator Evofem Biosciences, Inc. ("Evofem" or "the Company") today announced financial results for the third quarter and nine-month period ended September 30, 2024. Highlights ...

Siddiq’s words, however, indicate that, despite CMC objections, they are on the way ... by loading costs onto everyone who ...

Good morning and welcome to ImmuCell Corporation Reports Third Quarter September 30, 2024, Unaudited Financial Results Conference Call. All participants will be in listen-only mode. After today’s ...

A strong batting performance by the Windwards Islands Volcanoes’ top order helped to keep their slim hopes alive of making the semifinals of the ...

Robust firmonertinib monotherapy activity in front-line EGFR PACC mutant NSCLC including in patients with brain metastasesTop-line pivotal data ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Acurx Pharmaceuticals, Inc. Third ...

Stock analysts at B. Riley raised their FY2024 earnings per share (EPS) estimates for Koppers in a report issued on Monday, ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025 Company makes significant progress toward potential commerciali ...

An in-depth weekly look at NFL matchups and how they’ll affect your fantasy football lineup, with players you should start, ...